Serotonin modulates immune function in T cells from HIV-seropositive subjects

Area of Science:

• Immunology
• Neuroscience
• Virology

Background:

• Elevated intracellular cyclic adenosine monophosphate (cAMP) levels in lymphocytes of HIV-seropositive subjects are linked to reduced cell proliferation and cytotoxicity.
• Serotonin is known to decrease intracellular cAMP levels in normal lymphocytes.

Purpose of the Study:

• To investigate the effect of serotonin on intracellular cAMP levels and lymphocyte proliferation in HIV-seropositive individuals.
• To explore the role of the serotonin 5HT1a receptor in mediating these effects.
• To examine the impact of serotonin on the production of Interleukin-2 (IL-2) and Interferon-gamma (IFN-gamma).

Main Methods:

• Addition of serotonin to peripheral lymphocytes from HIV-seropositive subjects in vitro.
• Measurement of intracellular cAMP levels.
• Assessment of lymphocyte proliferation capacity.
• Quantification of mRNA expression for IL-2 and IFN-gamma.
• Use of DPAT, a specific 5HT1a receptor activator.

Main Results:

• Serotonin addition decreased intracellular cAMP levels in lymphocytes from HIV-seropositive subjects.
• Serotonin significantly increased in vitro lymphocyte proliferative capacity, with greater effects observed in individuals with higher initial responses.
• Serotonin increased mRNA expression for IL-2 and IFN-gamma in PHA-stimulated lymphocytes.
• DPAT mimicked the effects of serotonin, indicating mediation via the 5HT1a receptor.

Conclusions:

• Serotonin enhances lymphocyte proliferation in HIV-seropositive individuals, potentially through cAMP reduction and increased IL-2/IFN-gamma production, mediated by the 5HT1a receptor.
• The variable enhancement of proliferation suggests that factors beyond 5HT1a receptor expression levels influence serotonin's efficacy.